Nachrichten zur Boston Scientific Corp. Aktie

Peripheral Vascular Devices Market by Type, End User - Global Forecast to 2031

The global peripheral vascular devices market is set to reach USD 13.22 billion by 2031, growing at a CAGR of…

Wolfe Research cuts Boston Scientific rating as key growth drivers falter

Wolfe Research cuts Boston Scientific rating as key growth drivers falter…

BSX vs. ABT: Which Medical Stock Has More Upside Potential?

Boston Scientific and Abbott both posted solid quarterly growth, but analysts see stronger upside for Boston Scientific despite mounting operational…

Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts

Boston Scientific (BSX) concluded the recent trading session at $49.11, signifying a -2.68% move from its prior days close.…

Boston Scientific Aktie: WATCHMAN-Umsätze dürften kurzfristig stagnieren - Langfristige Wachstumsstory bleibt intakt

St. Louis (www.aktiencheck.de) - Boston Scientific-Aktienanalyse von Stifel:Rick Wise, Analyst von Stifel, stuft die Aktie von Boston Scientific Corporation (ISIN:…

Stock Market Today, May 27: Boston Scientific Plunges After Reiterating Underwhelming Full Year Growth Guidance

Investors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today, May 27, 2026.…

Why is Boston Scientific stock plunging today?

Why is Boston Scientific stock plunging today?…

Boston Scientific stock tumbles 6% after guidance cut

Boston Scientific stock tumbles 6% after guidance cut…

Boston Scientific Bets on WATCHMAN to Drive Structural Heart Growth

WATCHMANs 19% growth and trial wins bolster Boston Scientifics push to expand its addressable market from 5M to 20M patients…

Why Is Boston Scientific (BSX) Down 13% Since Last Earnings Report?

Boston Scientific (BSX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Boston Scientific: Revolutionärer Katheter und strategische Milliarden-Investitionen sollen das Wachstum antreiben!

Durchbruch bei Herzkranzgefäßen Boston Scientific (BSX) hat mit dem neuen SEISMIQ 4CE Katheter einen wichtigen Meilenstein erreicht. Für Laien erklärt:…

Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?

According to the average brokerage recommendation (ABR), one should invest in Boston Scientific (BSX). It is debatable whether this highly…

Boston Scientific stock gains on $2B share buyback plan

Boston Scientific stock gains on $2B share buyback plan…

Should You Buy, Hold or Sell BSX Stock Amid Cardiovascular Boom?

Boston Scientific rides on cardiovascular device growth with FARAPULSE and WATCHMAN momentum, but margin pressure and weaker estimates cloud the…

BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?

Boston Scientifics Neuromodulation unit posts 15% organic sales growth in Q1, fueled by pain management gains, the acquisition of Nalu…

Intuitive Surgical vs Boston Scientific: Which Stock Is the Better Buy Post Q1?

Intuitive Surgicals strong Q1 results, rising procedures, and raised outlook highlight accelerating growth, while Boston Scientific faces headwinds and tempered…

Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations

On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech leader’s…

U.S. stocks rally to records, but Brent oil also tops $100 on worries about Iran war

NEW YORK — The U.S. stock market rallied to more records Wednesday after GE Vernova, Boston Scientific and other big…

Boston Scientific cuts 2026 profit forecast, trims revenue growth view

Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a first-quarter earnings and revenue beat, while…

Boston Scientific (BSX) Q1 Earnings Match Estimates

Boston Scientific (BSX) delivered earnings and revenue surprises of +0.59% and +0.37%, respectively, for the quarter ended March 2026. Do…

BSX Q1 Earnings Match, 26 View Down, Stock Gains in Premarket

Boston Scientific meets Q1 EPS estimates, posts 11.6% revenue growth and beats sales estimates, but cuts 2026 outlook; shares still…

Will Robust Cardiovascular Performance Fuel BSXs Q1 Earnings?

Boston Scientific heads into Q1 earnings with strong Cardiovascular momentum and steady MedSurg growth, as estimates point to solid revenue…

Boston Scientific (BSX) Outperforms Broader Market: What You Need to Know

Boston Scientific (BSX) closed the most recent trading day at $64.61, moving +1.24% from the previous trading session.…

Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?

Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report?

Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…

Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Boston Scientific (BSX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff…

Boston Scientific (BSX) Stock Slides as Market Rises: Facts to Know Before You Trade

Boston Scientific (BSX) closed at $61.28 in the latest trading session, marking a -2.05% move from the prior day.…

Boston Scientific (BSX) Stock Sinks As Market Gains: Heres Why

In the most recent trading session, Boston Scientific (BSX) closed at $61.86, indicating a -1.17% shift from the previous trading…

Boston Scientific stock hits 52-week low at 61.23 USD

Boston Scientific stock hits 52-week low at 61.23 USD…

Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Boston Scientific (BSX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff…

Boston Scientific: From Hypergrowth To Durable Compounding

…

Heres Why Boston Scientific (BSX) Fell More Than Broader Market

In the closing of the recent trading day, Boston Scientific (BSX) stood at $62.93, denoting a -9.02% move from the…

Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results

Today, March 30, 2026, investors send Boston Scientific shares lower as they dig deeper into the companys latest trial update.…

Boston Scientific stock tumbles 9% on trial results

Boston Scientific stock tumbles 9% on trial results…

Stocks making the biggest moves midday: Fannie Mae, Boston Scientific, Blackstone, Palo Alto Networks and more

These are the stocks posting the largest moves in midday trading.…

Raymond James downgrades Boston Scientific but long-term story remains intact

Raymond James downgrades Boston Scientific but long-term story remains intact…

Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Boston Scientific (BSX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff…

Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know

Boston Scientific (BSX) concluded the recent trading session at $68.15, signifying a -2% move from its prior days close.…

Why Boston Scientific (BSX) Outpaced the Stock Market Today

Boston Scientific (BSX) closed the most recent trading day at $71.2, moving +2.02% from the previous trading session.…

INVESTOR DEADLINE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law

The case alleges Boston Scientific misled investors about its US EP segments growth and competitive risks.…

dpa-AFX ProFeed